A phase I/II open-label multicenter study of the cyclin kinase inhibitor AT7519M alone and in combination with bortezomib in patients with previously treated multiple myeloma Meeting Abstract
| Authors: | Raje, N.; Hari, P. N.; Landau, H.; Richardson, P. G.; Rosenblatt, J.; Couture, N.; Lyons, J. F.; Langford, G.; Yule, M. |
| Abstract Title: | A phase I/II open-label multicenter study of the cyclin kinase inhibitor AT7519M alone and in combination with bortezomib in patients with previously treated multiple myeloma |
| Meeting Title: | 55th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 122 |
| Issue: | 21 |
| Meeting Dates: | 2013 Dec 7-10 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2013-11-15 |
| Language: | English |
| ACCESSION: | WOS:000331385004163 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V122.21.1976.1976 |
| Notes: | Meeting Abstract: 1976 -- Source: Wos |
